K. Zuideveld

发表

Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.

M. Danhof, L. Thijs, E. Swart, 2003, British journal of clinical pharmacology.

A Dynamic Model of Hand‐and‐Foot Syndrome in Patients Receiving Capecitabine

C. Twelves, J. Cassidy, P. Hoff, 2009, Clinical pharmacology and therapeutics.

Systems Toxicology Modeling for Prediction in Humans

G. Helmlinger, R. Penland, T. Lavé, 2011 .

5‐HT7 receptor efficacy distribution throughout the canine stomach

K. Zuideveld, R. Lefebvre, P. Peeters, 2004, British journal of pharmacology.

Metabolic and cardiovascular effects of the adenosine A1 receptor agonist N6-(p-sulfophenyl)adenosine in diabetic Zucker rats: influence of the disease on the selectivity of action.

M. Danhof, A. IJzerman, K. Zuideveld, 1998, The Journal of pharmacology and experimental therapeutics.

Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients

B. Alexander, M. Pescovitz, A. Humar, 2005, Transplantation.

Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics.

Jan Fagerberg, René Bruno, Pascal Girard, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Model-based predictions of expected anti-tumor response and survival in phase III studies based on phase II data of an investigational agent.

J. Fagerberg, E. Van Cutsem, J. O’Shaughnessy, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetic-Pharmacodynamic Modeling of Buspirone and Its Metabolite 1-(2-Pyrimidinyl)-piperazine in Rats

L. Peletier, M. Danhof, P. H. van der Graaf, 2002, Journal of Pharmacology and Experimental Therapeutics.

Allometric Scaling of Pharmacodynamic Responses: Application to 5-Ht1A Receptor Mediated Responses from Rat to Man

Lambertus A. Peletier, Meindert Danhof, L. Peletier, 2007, Pharmaceutical Research.

Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier.

K. Zuideveld, D. Breimer, I. C. J. van der Sandt, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery.

Meindert Danhof, Catherijne A J Knibbe, M. Danhof, 2002, British journal of clinical pharmacology.

Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT1A receptor agonist flesinoxan.

L. Peletier, M. Danhof, P. H. van der Graaf, 2002, European journal of pharmacology.

Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.

M. Danhof, L. Thijs, E. Swart, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of 5-HT1A Receptor Agonists: Estimation of in Vivo Affinity and Intrinsic Efficacy on Body Temperature in Rats

L. Peletier, M. Danhof, P. H. van der Graaf, 2004, Journal of Pharmacology and Experimental Therapeutics.

time course of 8-OH-DPAT-induced hypothermia A set-point model with oscillatory behavior predicts the

L. Peletier, M. Danhof, J. Hulshof, 2016 .

Mechanism-Based Pharmacodynamic Modeling for Prediction of Exposure Response

M. Danhof, S. Visser, K. Zuideveld, 2004 .

A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.

Meindert Danhof, Lambertus A Peletier, L. Peletier, 2002, The Journal of pharmacology and experimental therapeutics.

A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia.

P H van der Graaf, M Danhof, L. Peletier, 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

5.38 – Mechanism-Based Pharmacokinetic–Pharmacodynamic Modeling for the Prediction of In Vivo Drug Concentration–Effect Relationships – Application in Drug Candidate Selection and Lead Optimization

M. Danhof, D. Jonker, S. Visser, 2007 .

Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients

M. Danhof, L. Thijs, E. Swart, 2006, European Journal of Clinical Pharmacology.

Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.

Meindert Danhof, Catherijne A J Knibbe, M. Danhof, 2005, British journal of clinical pharmacology.

Physiological Modeling of the Small Intestine in Drug Absorption

A. Schumitzky, D. DuBois, R. Almon, 2004 .

Population pharmacokinetic and pharmacodynamic modeling of propofol for long‐term sedation in critically ill patients: A comparison between propofol 6% and propofol 1%

J. DeJongh, M. Danhof, C. Knibbe, 2002, Clinical pharmacology and therapeutics.